Tripuraneni Radhika Insider Trades

Insider Trading History

Track insider trading activity for Tripuraneni Radhika. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $0 0 shares
Last Trade
May 05, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$10.1M 190,030 shares
$52.97
$52.95
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Medical Officer
Holding Value $1.66M 95,800 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.48M 114,950 shares
$30.25
$17.28
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $89.9k 1,697 shares
Last Trade
Feb 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58.7k 1,697 shares
$34.60
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $2.38M 45,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$185k 45,000 shares
$4.10
$52.95
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Medical Officer
Holding Value $5.37M 310,700 shares
Last Trade
Mar 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.84M 310,700 shares
$15.58
$17.28
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Mar 10, 2025 Sale
$623k 40,000 shares
$15.58
$17.28
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $564k 10,657 shares
Last Trade
Feb 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.5k 10,657 shares
$4.46
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $248k 4,676 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32k 4,676 shares
$6.85
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $1.69M 32,000 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$224k 32,000 shares
$6.99
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $1.69M 32,000 shares
Last Trade
Jun 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$386k 32,000 shares
$12.05
$52.95
Terns Pharmaceuticals
Terns Pharmaceuticals TERN
Director
Holding Value $3.39M 64,000 shares
Last Trade
Jul 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$136k 64,000 shares
$2.13
$52.95
Prothena plc
Prothena plc PRTA
Chief Development Officer
Holding Value $478k 50,000 shares
Last Trade
Feb 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.62M 50,000 shares
$32.45
$9.55
Prothena plc
Prothena plc PRTA
Chief Development Officer
Holding Value $535k 56,000 shares
Last Trade
Feb 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 56,000 shares
$22.60
$9.55
Prothena plc
Prothena plc PRTA
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Feb 12, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.14M 50,000 shares
$22.85
$9.55
Prothena plc
Prothena plc PRTA
Chief Development Officer
Holding Value $354k 37,037 shares
Last Trade
Feb 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$846k 37,037 shares
$22.85
$9.55
Prothena plc
Prothena plc PRTA
Chief Development Officer
Holding Value $669k 70,000 shares
Last Trade
Feb 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$851k 70,000 shares
$12.15
$9.55
Prothena plc
Prothena plc PRTA
Chief Development Officer
Holding Value $478k 50,000 shares
Last Trade
Feb 27, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$677k 50,000 shares
$13.53
$9.55
Prothena plc
Prothena plc PRTA
Chief Development Officer
Holding Value $334k 35,000 shares
Last Trade
Dec 11, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$407k 35,000 shares
$11.63
$9.55
Prothena plc
Prothena plc PRTA
Chief Development Officer
Holding Value $0 0 shares
Last Trade
Dec 11, 2018 Sale
$1.51M 130,000 shares
$11.63
$9.55

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up